Point72 Middle East Fze Design Therapeutics, Inc. Transaction History

Point72 Middle East Fze

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.99 - $2.76 $8,956 - $12,422	4,501 Added 91.39%	9,426 $24,000
Q3 2023 Nov 14, 2023	SELL	$2.05 - $8.14 $8,528 - $33,862	-4,160 Reduced 45.79%	4,925 $11,000
Q2 2023 Aug 14, 2023	SELL	$4.99 - $7.64 $1,392 - $2,131	-279 Reduced 2.98%	9,085 $57,000
Q1 2023 May 15, 2023	BUY	$5.5 - $9.77 $51,502 - $91,486	9,364 New	9,364 $54,000

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $347M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.